Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe

J Med Econ. 2014 Dec; 17(12):837-45

View abstract

Authors

Campone M, Yang H, Faust E, Kageleiry A, Signorovitch JE, Zhang J, Gao H.